Case 1 involved transformation from cHL to CD20+/CD30+ DLBCL following multiple lines of chemotherapy and autologous stem cell transplant, eventually resulting in progressive disease and death. The gene discussed is TNFRSF8; the disease is diffuse large B-cell lymphoma.